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Abstract
Background: Myocardial perfusion single photon emission computed tomography (MPS) is frequently
used as the reference method for the determination of myocardial infarct size. PERFIT® is a software
utilizing a three-dimensional gender specific, averaged heart model for the automatic evaluation of
myocardial perfusion. The purpose of this study was to compare the perfusion defect size on MPS,
assessed with PERFIT, with the hyperenhanced volume assessed by late gadolinium enhancement magnetic
resonance imaging (LGE) and to relate their effect on the wall motion score index (WMSI) assessed with
cine magnetic resonance imaging (cine-MRI) and echocardiography (echo).
Methods: LGE was performed in 40 patients where clinical MPS showed an irreversible uptake reduction
suggesting a myocardial scar. Infarct volume, extent and major coronary supply were compared between
MPS and LGE as well as the relationship between infarct size from both methods and WMSI.
Results: MPS showed a slightly larger infarct volume than LGE (MPS 29.6 ± 23.2 ml, LGE 22.1 ± 16.9 ml,
p = 0.01), while no significant difference was found in infarct extent (MPS 11.7 ± 9.4%, LGE 13.0 ± 9.6%).
The correlation coefficients between methods in respect to infarct size and infarct extent were 0.71 and
0.63 respectively. WMSI determined with cine-MRI correlated moderately with infarct volume and infarct
extent (cine-MRI vs MPS volume r = 0.71, extent r = 0.71, cine-MRI vs LGE volume r = 0.62, extent r =
0.60). Similar results were achieved when wall motion was determined with echo. Both MPS and LGE
showed the same major coronary supply to the infarct area in a majority of patients, Kappa = 0.84.
Conclusion: MPS and LGE agree moderately in the determination of infarct size in both absolute and
relative terms, although infarct volume is slightly larger with MPS. The correlation between WMSI and
infarct size is moderate.
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Coronary artery disease (CAD) is currently the leading
cause of death in industrialized countries and a growing
concern in low- and middle-income countries [1]. Infarct
size is a powerful prognostic predictor for survival in
patients with CAD and left ventricular (LV) dysfunction
[2,3]. It forecasts the risk of developing heart failure,
which in turn influences the choice of medical treat-
ment, catheter intervention or surgery. Hypokinetic left
ventricular wall segments with stunned or hibernating
myocardium are viable and function may return after
revascularization. The potential reversibility of chronic
LV dysfunction is thus an important consideration in
patients with heart failure [4]. Moreover, infarct size may
be an attractive surrogate end point in studies of infarct
limiting interventions after acute myocardial infarction
[5-7].
Myocardial perfusion single photon emission computed
tomography (MPS) has often been used as a reference
method to estimate infarct size [8], based on visual quali-
tative evaluation of the perfusion defect. Objective meas-
urement and standardized evaluation are desirable in the
application of all cardiac imaging methods. Hoffmann et
al [9] showed that physicians employed in the same echo
lab agreed well in wall motion assessment but less so
when compared with physicians trained in other hospi-
tals. Computer-assisted assessment of infarct size in MPS
imaging may reduce the variability between different
observers [10,11]. PERFIT® (HERMES Medical Solutions,
Stockholm, Sweden) is an automatic software package for
quantitative analysis of infarct size and severity. The refer-
ence is a three-dimensional, gender specific, averaged
heart, generated from a defined reference population
[12,13].
Late gadolinium enhancement magnetic resonance
imaging (LGE) accurately determines infarct size [14]
and has a high reproducibility [15]. A high spatial reso-
lution enables measuring infarct transmurality and from
this parameter assessment of viable myocardium is pos-
sible [16-18].
Previous studies have shown a good agreement
between infarct size assessed with MPS and LGE [6,19-
21]. The purpose of the present study was to compare
the perfusion defect size by MPS, assessed with an auto-
mated infarction size evaluation software, PERFIT, with
the hyperenhanced volume measured with LGE, in
patients with a perfusion defect suggestive of infarction
on MPS. The relationship between ventricular function
and infarct size as well as the major coronary supply to




Forty patients, 33 men and 7 women, average age 65 ± 10
years (range 36 – 84) were consecutively enrolled between
June 2002 and March 2004. Thirty-two of these patients
had been diagnosed with myocardial infarction and the
remaining 8 had symptoms suggestive of coronary artery
disease. Fourteen patients had been revascularized, either
with open heart surgery or percutaneous coronary inter-
ventions. Patients referred for MPS with suspicion of cor-
onary artery disease were included in the study if they had
an irreversible uptake reduction suggesting a myocardial
scar. Exclusion criteria were contraindications for mag-
netic resonance imaging (MRI) such as an implantable
cardiac device, ferromagnetic clips, claustrophobia, or an
intercurrent cardiovascular event between the studies such
as revascularization or myocardial infarction. No patient
was excluded because of technical failure or poor image
quality. MPS and LGE were performed within 42 ± 34
days (range 10 – 192). The study was approved by the Eth-
ics committee at Linköping University and complied with
the Declaration of Helsinki. All patients gave informed
consent.
Myocardial perfusion imaging
The rest images from a two-day stress/rest protocol were
used. Imaging at rest was performed 2 – 3 days after stress
imaging using 8.6 MBq 99mTc tetrofosmin/kg bodyweight
(max 860 MBq) (Amersham Health, Buckinghamshire,
UK). A dual-detector gamma camera (E. CAM, Siemens
Medical Systems Inc, Hoffman Estates, Il, USA) equipped
with a high resolution collimator was used. Thirty-two
views were acquired in steps of 2.8 degrees per detector
and the acquisition time/angle was 25 s. (In the first nine
patients, 16 views per detector were used with an acquisi-
tion time/angle of 50s). A 19% window was "asymmetri-
cally placed" (129 – 155 keV) on the 140 keV peak. A
64*64 word matrix with a pixel size of 6.6 mm was used.
The acquisition files were reconstructed by the nuclear
technicians using filtered back-projection prefiltered with
a Butterworth filter (cut off 0.8/cm, order 10) (Hermes
Medical Solutions, Stockholm, Sweden) and the short-
axis slices were manually re-oriented perpendicular to the
cardiac long axis. In case of interfering bowel uptake,
acquisition was repeated after intake of fluids. The result
of the reconstruction procedure was controlled and the
images were initially analyzed and reported for clinical
patient care by four experienced nuclear physicians,
whose individual evaluations were the basis for inclusion
in the study. After inclusion, images at rest were reana-
lyzed with PERFIT by one expert reader without knowl-
edge of the LGE results. PERFIT compares manually
reconstructed transversal slices using an automated image
alignment algorithm with a three-dimensional genderPage 2 of 8
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reference population. The software assesses the size of the
myocardial scar (ml), the infarct extent (% of myocardial
volume) and analyzes the percentage of each coronary
artery perfusion area involved [12,13]. The threshold for
MPS scar is set to an absolute level of < 2 SD of the highest
perfusion uptake in a remote area of the myocardium. In
the PERFIT analysis, the image alignment by the software
was visually checked but no manual correction of the
automatic fit was necessary. This totally automatic volu-
metric MPS technique was chosen in favour of polar-maps
since the presentation of the short-axis slices is identical to
that of LGE, thus allowing a simplified visual infarct inter-
pretation.
Magnetic resonance imaging
The patients were placed in the magnet (1.5 T Magnetom-
Vision, Siemens, Erlangen, Germany) in supine position.
A circular polarized body-array surface coil was used in all
measurements. ECG-triggered MR images were obtained
during repeated breath-holds. Cine-MR imaging
attempted to cover the entire left ventricle with on average
9 (range 7 – 11) short-axis slices and three long axis planes
(2, 3 and 4 chamber views). A turbo-fast low angle shot
(FLASH) sequence with repetition time 100 ms and echo
time 4.8 ms was used. The contrast-enhanced images were
acquired at the same slice positions as the cine-images.
Gadopentetate dimeglumine (Gd-DTPA) 0.2 mmol/kg
bodyweight (Schering Nordiska AB, Järfälla, Sweden) was
administered in 33 patients and 0.1 mmol/kg bodyweight
in the initial seven patients. A segmented IR turbo-FLASH-
sequence was used, with a repetition time determined by
2 R-R intervals, an echo time of 3.4 ms and an inversion
time of 175–250 ms with 300 ms delay after the R-wave.
Slice thickness was 8 mm, intersection gap 2 mm, field-of-
view 270 × 360 mm and image matrix 132 × 256. The seg-
mented sequence acquired 33 k-space lines following the
inversion pulse. A 300 ms delay forced the data acquisi-
tion to the diastolic phase. The total acquisition time per
slice was 10 heartbeats including one magnetization
steady-state preparation period. Optimal contrast
between hyperenhanced areas and normal myocardium
was established by continually adjusting the inversion
time to null the signal from the healthy myocardium. The
CNR (contrast-to-noise ratio) obtained was 6.8 ± 3.3.
Left ventricular myocardial volume and infarct size were
measured twice on the LGE images by two observers, both
without knowledge of the results from the MPS measure-
ments. Segmentation of the myocardium and the infarct
area was performed manually with planimetry using
ImageJ 1.29× (Wayne Rasband, NIH USA, http://
rsb.info.nih.gov/ij/). The infarct area was set to a signal
intensity exceeding 2 SD. of the signal intensity in a
remote area of the myocardium. Infarct extent was calcu-
lated as the percentage of scar compared with the total
volume of the myocardium. Long axis views aided the
determination of scar. The papillary muscles were
included in the LV size/infarction size if they were
attached to the myocardium at that particular site. The
volume of the infarct and of the healthy myocardium was
averaged from the two observers and infarct size was
expressed as volume and extent. Problems with partial
volume effects, due to thick slices, in the apex and in the
left ventricular outflow tract were resolved by consensus
(6% of all slices). Wall motion scoring was performed in
the same manner as with echocardiography (see below).
Echocardiography
Left ventricular function was determined with echocardi-
ography (Siemens Sequoia 256, Siemens Healthcare Inc,
Mountainview, CA, USA) on the same day as the MRI
examination. The patients were investigated in the left lat-
eral position, with 2D recordings from the apical and par-
asternal positions. Cineloops were digitized and stored on
magneto-optic discs (MO) as well as 10s views stored on
video tape. The left ventricle was divided into 16 segments
[22]. Wall motion was determined by two independent
observers and the mean value was applied to each seg-
ment. Wall motion scoring used the following semi quan-
titative values: normal = 1, hypokinetic = 2, akinetic = 3,
dyskinetic = 4, aneurysm = 5. Scores were summed and
divided by the 16 segments to obtain a global wall motion
score index for the left ventricle for each patient.
Coronary artery supply area
In the 33 patients where an infarct scar was seen on both
MPS and LGE, the major coronary artery supply for the
infarcted segments in LGE was manually determined
according to a 16 myocardial segmental model that
closely resembles the presently recommended 17-seg-
ment model [22,23]. The left ventricle was divided into
equal thirds perpendicular to the long axis of the heart. A
mid-slice in each third was selected and the segmental scar
area calculated after manually outlining the epi- and
endocardial borders [24]. The late gadolinium positive
fraction in each coronary artery perfusion area was calcu-
lated, provided the percentage involvement of any seg-
ment exceeded 5%. All segments were assumed to be of
equal size. The coronary perfusion area with the highest
infarct fraction was assumed to be perfused by the infarct
related artery. For MPS, the software gave a figure of inf-
arcted volume for each coronary artery perfusion area. The
coronary perfusion area with the highest infarct fraction
was assumed to be the infarct related artery.
Statistical analysis
Analyses were performed using SPSS 13.0 (SPSS Inc, Chi-
cago, Illinois). Values are reported as mean ± SD. For inf-
arct size and extent, two-sided t-test for pairedPage 3 of 8
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related p values are reported and Bland-Altman plots
used. Kappa statistics was used to determine the corre-
spondence between the two methods in the determina-
tion of the major vascular supply of the infarcted region.
Results
The myocardial infarct volume assessed with MPS was
29.6 ± 23.2 ml (range 0 – 87) compared with LGE 22.1 ±
16.9 ml (range 0 – 69), p = 0.01, with a correlation coeffi-
cient of r = 0.71, figure 1 and table 1. Infarct extent was
11.7 ± 9.4% (range 0 – 38) using MPS and 13.0 ± 9.6%
(range 0 – 35) with LGE, p = 0.32, with a correlation coef-
ficient of r = 0.63, figure 2. The intraobserver variability
for LGE infarct volume was 0.3 ± 8.0 ml and 0.2 ± 6.4 ml
respectively for the two observers and for LGE infarct
extent 0.1 ± 4.3% and 0.2 ± 3.8 respectively. Interobserver
variability for LGE infarct volume was 1.0 ± 3.0 ml (p =
0.05) and for infarct extent 0.3 ± 2.4% (p = 0.4).
PERFIT and LGE were concordant in 34 patients, while
there were differences in six patients. In five patients with
normal LGE results, PERFIT and clinical evaluation
reported myocardial perfusion defects. A retrospective
review of these MPS studies showed that attenuation
defects were possible. In one patient, PERFIT did not
detect a scar that was reported from clinical MPS evalua-
tion and with LGE. Additionally, clinical MPS erroneously
reported a scar in one patient that was cleared with PERFIT
as well as LGE, see table 2, figures 3 and 4. If these 7
patients were removed from the analysis, infarct volume
assessed with MPS was 33.2 ± 23.5 ml and with LGE 26.7
± 14.9 ml, (p = 0.04). Infarct extent was 13.2 ± 9.6% with
MPS and 15.7 ± 8.3% with LGE, (p = 0.08). The correla-
tion coefficient between the two methods was in this sub-
set 0.70 for infarct volume and 0.59 for infarct extent.
Contrary to the general impression, in three patients, the
LGE analysis suggested a larger infarct volume and/or
extent than MPS (> 1 SD of their difference). In two of
these cases, the infracted area included the apex which
made delineation of the endocardium difficult due to low
contrast between the infarct area and the signal in the
blood pool. In the third patient, bowel uptake on MPS-
images interfered with the interpretation of the inferior
perfusion reduction. In six studies MPS showed a larger
infarct volume and/or extent compared with LGE (> 1
SD). In two of these studies MPS showed a reduced uptake
where LGE showed thin walls and in four patients MPS
showed reduced inferior uptake where LGE showed a
small inferior infarct or no scar at all. In three of these four
patients both MPS and LGE displayed dilated left ventri-
cles.
Wall motion score index determined with cine-MRI and
with echo correlated reasonably well with infarct volume
and extent with both MPS and LGE. The correlation
WMSI(cine-MRI) versus infarct volume(MPS) was r = 0.71
and infarct extent(MPS) r = 0.71. WMSI(echo) vs infarct
volume(MPS) was r = 0.64 and for infarct extent r = 0.65,
respectively, figure 5. WMSI (cine-MRI) vs infarct vol-
ume(LGE) was r = 0.62 and infarct extent(LGE) r = 0.60.
WMSI(echo) versus infarct volume (LGE) was r = 0.57 and
infarct extent r = 0.56 respectively, figure 6.
In the 33 scans where MPS and LGE both showed myocar-
dial scars, PERFIT determined that LAD was the main cor-
onary artery supply of the infarcted segments in 21 scans
(LAD territory involvement in a total of 25 exams),
whereas LCx and RCA were the main coronary artery sup-
ply in 6 scans each (LCx and RCA territory involvement in
a total of 19 and 16 exams respectively). Corresponding
figures with LGE were for LAD 20 scans (LGE uptake in a
total of 107 segments) and for LCx and RCA 5 and 8 scans
respectively (LGE uptake in a total of 63 segments and 71
segments respectively). Hence, there was a good agree-
ment in 30 of the 33 scans with myocardial damage,
(Kappa = 0.84).
Discussion
In this study, the mean infarct volume from MPS, evalu-
ated with a fully automatic computer software, was
slightly larger than manually delineated LGE. This is in
line with previous results, usually obtained with visual
expert readings of either standard tomographic projec-
tions or polar map displays. PERFIT is fast and does not
seem to miss clinically relevant hypoperfused areas. The
Achilles heel of any automated perfusion software is the
issue of breast and abdominal attenuation. In a gated
SPECT presentation, the absence of wall motion distur-
bance suggests attenuation rather than scar. Despite the
lack of such checks and balances in PERFIT, the agreement
with LGE is in line with conventional methods. Medrano
et. al [25] compared the sestamibi perfusion defect with
Table 1: Infarct volume and infarct extent
MPS LGE Difference 95% CI for difference r p
Infarct volume (ml) 29.6 22.1 -7.5 -12.7 to -2.3 0.71 0.01
Infarct extent (%) 11.7 13.0 1.3 -1.3 to 3.9 0.63 0.32
MPS automatic calculation and LGE averaged from manual measurements of 2 observers.Page 4 of 8
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hearts with ischemic cardiomyopathy. They found a good
agreement between the two techniques (r = 0.89)
although there was a slight overestimation with MPS.
When comparing MPS and LGE in acute as well as chronic
studies, Hedstrom et.al [19] found that the MPS perfusion
defect was slightly larger than the hyperenhanced volume
by LGE. Using a different tracer, 201Tl, a similar result was
found by Lund et. al with MPS showing a slightly larger
infarct extent compared to LGE (r = 0.73) in 60 patients
with acute myocardial infarction [20]. Fieno et.al, com-
paring patients with chronic coronary artery disease,
found a correlation of r = 0.76 between rest 201Tl and LGE
[21]. Interestingly, they found a higher correlation, r =
0.90, when comparing re-distribution 201Tl MPS and LGE
in the same patient group. The authors suggested that the
stronger relationship in redistribution 201Tl MPS is closely
related to the potassium space which is assumed to be
more reflective of the amount of viable myocardial cells.
If so, tetrofosmin does not redistribute and cannot be
expected to follow the potassium distribution. Our find-
ings thus agree well with rest-201Tl MPS in the Fieno study
[21].
The difference in infarct size between the MPS and LGE
can be due to several physiological mechanisms being
active in the different techniques. MPS represents the per-
fusion of the myocardium and the tracer uptake is
dependent on the blood flow. In LGE, the myocardial scar
is enhanced by the presence of extracellular Gd-DTPA and
the concentration depends on the washout kinetics of the
extracellular space [26,27]. Spatial resolution is approxi-
mately 10 times higher with LGE than with MPS causing
a larger partial volume effect with MPS. This lowers the
efficacy of MPS to detect subendocardial scar, but not for
the detection of transmural infarcts [28]. Also various
acquisition and reconstruction parameters such as choice
of filters and filter parameters may affect the quantitative
results in MPS [29]. Ibrahim et.al [6] found that the scar
size with LGE depends on the inversion time. Maintaining
a constant inversion time resulted in a decrease of both
signal and infarct extent on late acquisitions. If the inver-
sion time was adjusted, the image contrast stayed at a high
level for 42 minutes (437% of remote area). In our study,
all LGE recordings were performed within this time span.
In four of the six studies where MPS showed infarct size
exceeding + 1 SD compared with LGE, MPS displayed
hypoperfused myocardium in the inferior wall. Also, in
three of the five examinations where MPS suggested myo-
cardial infarction but LGE did not, there was reduced MPS
perfusion in the inferior wall. Previous studies have
shown that LGE has a higher sensitivity for a myocardial
scar in the posterior – inferior region [30], especially in
the setting of a nontransmural infarct [31]. McCrohon et.
al found that only approximately 25% of patients with
presumed inferior attenuation defect on MPS have abnor-
malities on LGE [32]. It is likely that diaphragmatic/soft
tissue attenuation artefacts could be one explanation for
the false positive MPS exams in our study. Another possi-
ble explanation could be a reduced wall thickness [33].
This was our visual impression in two of the six patients
where the MPS infarct extent was > 1 SD larger than the
LGE extent.
Left ventricular function can be expected to be linearly
related to the volumetric infarct size [34]. If not, other
mechanisms such as excessive reduction in left ventricular
systolic function e.g. due to stunning or hibernation could
be invoked. As expected, in this study left ventricular func-
tion, estimated from the calculation of wall motion score
Infarct volumeFigure 1
Infarct volume. Determination of infarct volume. LGE vs 
MPS (left). Regression line is shown. Corresponding Bland-
Altman plot (right). Values are averaged from two observers.
Infarct extentFigure 2
Infarct extent. Determination of infarct extent. LGE vs 
MPS (left). Regression line is shown. Corresponding Bland-
Altman plot (right). Values are averaged from two observers.Page 5 of 8
(page number not for citation purposes)
BMC Medical Imaging 2008, 8:17 http://www.biomedcentral.com/1471-2342/8/17index from cine-MRI as well as from echo, correlated
moderately with infarct size, assessed with both MPS and
LGE.
Limitations
The initial seven patients received "single dose" (0.1
mmol/kg bodyweight) of intravenous gadolinium, which
is less than the standard dose but still provides excellent
image contrast [35]. The results from this study show that
the difference in infarct volume and extent between MPS
and LGE in these seven patients was less than 1 SD. In
some patients there was a considerable time span between
the initial MPS and the LGE exams. However, there was no
intercurrent cardiovascular event between the exams and
the 5 patients with the longest time difference (> 64 days)
did not show larger deviation in infarct size than those
with a shorter time span. Patient selection was based on
the presence of a perfusion defect, which in some patients
could be due to an attenuation artefact, possibly weaken-
ing the correlation between infarct size with the two meth-
ods. However, after excluding patients where neither MPS
nor LGE showed myocardial scar, the correlation between
MPS and LGE changed very little, showing that the corre-
lation was rather robust for the influence of attenuation.
The detection limit for LGE uptake is conventionally felt
to be in the range of 1 ml, which could represent less than
1% of the myocardial volume. In MPS, the clinical cut-off
for scar detection with PERFIT is set at 2% of the myocar-
dial volume, which is considerably larger than with LGE.
Finally, the change in the acquisition protocol for MPS
from 32 to 64 views with a reduction of acquisition time
from 50 to 25s after the first nine patients was done in
order to optimize MPS acquisition. This change foremost
reduced streak artefacts and, of less importance, improved
spatial resolution.
Conclusion
MPS and LGE agree fairly well in the determination of inf-
arct size in both absolute and relative terms, although inf-
arct volume is slightly larger with MPS. This could be due
to physical factors in the reconstruction algorithm such as
filter choice and cut off, the absence of scatter correction,
differences in the segmentation, or biological factors such
as hypoperfused myocardium and wall thinning. The cor-
relation between WMSI and infarct size was moderate
Table 2: Concordance between MPS and LGE
LGE normal LGE pathologic Sum
MPS(Perfit) normal 1 1 2
MPS(Perfit) pathologic 5 33 38
Sum 6 34 40
Normal and pathologic results reported with the two methods.
Subendocardial anteroseptal infarct where MPS and LGE agreeFigure 3
Subendocardial anteroseptal infarct where MPS and 
LGE agree. Upper row: Left – evaluation of the scar by 
MPS(Perfit) in short-axis view. Middle – corresponding image 
without automatic scar determination. Right – corresponding 
long axis view. Lower row: Left – manual evaluation of the 
scar on LGE image in short axis view. Middle – correspond-
ing image without manual evaluation. Right – corresponding 
long axis view.
Discordance between MPS and LGE. MPS shows inferior inf-arct whereas LGE shows normal myocardiumFigure 4
Discordance between MPS and LGE. MPS shows infe-
rior infarct whereas LGE shows normal myocardium. 
For explanation see figure 3.Page 6 of 8
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tion in the subjective assessment of wall motion.
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